Why 2020 could be a make-or-break year for Novavax By: Washington Business Journal via Business Journals November 08, 2019 at 15:04 PM EST A new year will bring phase 3 trial results for Novavax's flu vaccine — and the company's got a lot riding on them. Read More >>
